Bicycle Therapeutics CEO Kevin Lee Sells Shares to Cover Tax Obligations

This Form 4 filing reports that Kevin Lee, CEO and Director of Bicycle Therapeutics PLC, sold 7,642 ordinary shares in two transactions on July 2 and July 6, 2026. The sales were executed to cover statutory tax withholding obligations related to the vesting and settlement of restricted stock units (RSUs). The first sale of 5,905 shares occurred at a weighted average price of $4.27 per share, while the second sale of 1,737 shares was at $4.31 per share. According to footnotes, these were "sell to cover" transactions mandated by Lee's award agreement to satisfy minimum tax withholding requirements, not discretionary sales. Following these transactions, Lee's ownership decreased from 605,408 to 603,671 ordinary shares. The filing emphasizes that these sales were non-discretionary and required to meet tax obligations rather than representing a change in investment strategy.